Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Nov 20, 2020 6:51pm

712 Views

Post# 31945625

todays trades

House Positions for C:VXL from 20201120 to 20201120

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
85 Scotia	21,989	1,969	0.09	0			21,989	-1,969
1 Anonymous	35,000	2,975	0.085	13,744	1,233	0.09	21,256	-1,742
80 National Bank	20,000	1,800	0.09	0			20,000	-1,800
68 Leede	588	49	0.083	0			588	-49
7 TD Sec	26,000	2,210	0.085	28,863	2,453	0.085	-2,863	243
33 Canaccord	0			5,000	450	0.09	-5,000	450
2 RBC	20,744	1,773	0.085	76,714	6,639	0.087	-55,970	4,866
TOTAL	124,321	10,776	0.087	124,321	10,775	0.087	0	-1